Tobin W. Juvenal - 12 Jan 2026 Form 4 Insider Report for CASTLE BIOSCIENCES INC (CSTL)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
14 Jan 2026, 16:30:07 UTC
Prior SEC filing
15 Dec 2025
Next SEC filing
05 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Frank Stokes, Attorney-in-Fact

Key filing fact

Tobin W. Juvenal filed Form 4 for CASTLE BIOSCIENCES INC (CSTL) on 14 Jan 2026.

Key facts

  • This page summarizes Tobin W. Juvenal's Form 4 filing for CASTLE BIOSCIENCES INC (CSTL).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 14 Jan 2026, 16:30.

Change

  • Previous filing in this sequence was filed on 15 Dec 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001856542 Primary reporting owner

Juvenal Tobin W

Relationship
Chief Commercial Officer
Address
C/O CASTLE BIOSCIENCES, INC., 505 S. FRIENDSWOOD DRIVE, SUITE 401, FRIENDSWOOD
Signature
/s/ Frank Stokes, Attorney-in-Fact
Signature date
14 Jan 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CSTL transaction

Common Stock

Award

Transaction value
$0
Shares
+9,207
Change %
+11%
Price
$0.000000
Shares after
96,032
Date
12 Jan 2026
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CSTL transaction Derivative

Performance-Based Stock Unit

Award

Transaction value
$0
Shares
+9,207
Change %
Price
$0.000000
Shares after
9,207
Date
12 Jan 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
9,207
Exercise price
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents 50% of the Performance-Based Stock Units ("PSUs") granted on March 4, 2024 ("2024 PSUs") that vested based on the satisfaction of certain performance criteria as certified by the board of directors of the Issuer on January 12, 2026.

Footnote F2

Each PSU represents the right to receive one share of the Issuer's Common Stock. These PSUs represent the remaining 50% of the 2024 PSUs which will vest subject to the achievement of certain milestones.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .